Disc Medicine Inc (NAS:IRON)
$ 34.14 -0.52 (-1.5%) Market Cap: 844.00 Mil Enterprise Value: 516.26 Mil PE Ratio: 0 PB Ratio: 2.49 GF Score: 32/100

Disc Medicine Inc at H.C. Wainwright BioConnect Investor Conference Transcript

May 02, 2023 / 06:30PM GMT
Release Date Price: $32.6 (-5.81%)
Doug Tsao
H.C. Wainwright & Co. LLC - Senior Analyst

Welcome, everybody. I'm Doug Tsao, senior analyst at H.C. Wainwright. We are thrilled to have our next session with Disc Medicine, represented by John Quisel.

John Quisel
Disc Medicines, Inc. - CEO

Quisel.

Questions & Answers

Doug Tsao
H.C. Wainwright & Co. LLC - Senior Analyst

Quisel. Sorry. My apologies. So we'll sort of jump into it. So you're a relatively new company to the public markets after your merger with Gemini Therapeutics. So maybe provide a quick overview of the company, what it was founded, and your vision, and what you're trying to accomplish.

John Quisel
Disc Medicines, Inc. - CEO

Yes, thanks. Great to be here today. Appreciate the time. So, Disc Medicine, we went public through a reverse merger with Gemini Therapeutics just at the end of last year. So we've been public now for a few months. Our vision is to build a great hematology company. We think this is a fantastic area for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot